CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research

The second project "A unique platform to harness the hidden potential of RNA-binding proteins involved in brain diseases" led by Jean-Martin Beaulieu at the Dept. of Pharmacology, University of Toronto
is a public-private collaboration with Keith Murai at the Research Institute of the McGill University Health Centre and David Hunt at Imstar Therapeutics in Vancouver.
- $1.488 M over three years.

Read more: http://www.braincanada.ca/files/Focus_on_Brain_press_release_EN_Final.pdf